Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06349434 · ClinicalTrials.gov registry record · NA

The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI

A NA study of SCI - Spinal Cord Injury and Upper Extremity Dysfunction, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06349434 is a NA study of SCI - Spinal Cord Injury and Upper Extremity Dysfunction that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 60 participants, above the 33-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06349434, a NA study of SCI - Spinal Cord Injury and Upper Extremity Dysfunction, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

To evaluate the usefulness of an upper extremity assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury. The Department of Defense is supporting this study.

Interventions

  • DEVICE MyoMo
  • OTHER conventional therapy

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-15
Est. Completion 2028-10-01
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT06349434

The ClinicalTrials.gov registry entry for NCT06349434 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 33-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (82% higher). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which MyoMo is the first listed.

NCT06349434 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06349434 about?

NCT06349434 is a clinical study titled "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI". To evaluate the usefulness of an upper extremity assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury. The Department of Defense is supporting this study.

What is the current status of trial NCT06349434?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-10-15. Estimated completion is 2028-10-01.

What conditions does trial NCT06349434 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury, Upper Extremity Dysfunction, Upper Extremity Problem.

What interventions are being tested in trial NCT06349434?

The interventions under investigation include: MyoMo (DEVICE), conventional therapy (OTHER).

Who is sponsoring clinical trial NCT06349434?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06349434 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.